Literature DB >> 10613597

Enhancement of radiosensitivity in human glioblastoma U138MG cells by tetrandrine.

K H Chang1, M L Chen, H C Chen, Y W Huang, T Y Wu, Y J Chen.   

Abstract

Tetrandrine, a natural lipid-soluble alkaloid with a low molecular weight, has both anti-tumor activity and a tissue-protective effect, as demonstrated in our previous studies. We studied tetrandrine to determine whether or not it enhanced radiosensitivity in human glioblastoma U138MG cells. Tetrandrine at concentration of 5.0 and 7.5 eg/ml dramatically enhanced the growth-inhibiting effect of radiation. This effect is dose-dependent on the dose of both tetrandrine and radiation. Moreover, we found that tetrandrine eliminated the cell cycle perturbation induced by radiation. Cells treated with tetrandrine alone as well as with a combination of tetrandrine and radiation became rounded, floated up and grew sparsely under observation under an inverted light microscope, DNA fragmentation was also noted by gel electrophoresis. These findings suggest that tetrandrine has potential as an adjunct to radiotherapy for glioblastoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10613597

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  11 in total

1.  Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells.

Authors:  Jun Wang; Lihong Chang; Xiaoping Lai; Xia Li; Zhiyuan Wang; Zizhen Huang; Jiancong Huang; Gehua Zhang
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

Review 2.  Cl- and K+ channels and their role in primary brain tumour biology.

Authors:  Kathryn L Turner; Harald Sontheimer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

Review 3.  Ion channels in cancer: future perspectives and clinical potential.

Authors:  Florian Lang; Christos Stournaras
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-02-03       Impact factor: 6.237

4.  Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17.

Authors:  Zhichao Wu; Guangzhi Wang; Shaoqian Xu; Yang Li; Yu Tian; Hongshuang Niu; Fei Yuan; Fenggang Zhou; Zhen Hao; Yongri Zheng; Qingsong Li; Jianjiao Wang
Journal:  Tumour Biol       Date:  2013-11-03

5.  Tetrandrine attenuated cerebral ischemia/reperfusion injury and induced differential proteomic changes in a MCAO mice model using 2-D DIGE.

Authors:  Lin Ruan; Huan-Sen Huang; Wen-Xiang Jin; Hai-Ming Chen; Xiong-Juan Li; Qing-Juan Gong
Journal:  Neurochem Res       Date:  2013-06-19       Impact factor: 3.996

Review 6.  The potential of tetrandrine as a protective agent for ischemic stroke.

Authors:  Yun Chen; Ya-Hui Tsai; Sheng-Hong Tseng
Journal:  Molecules       Date:  2011-09-16       Impact factor: 4.411

7.  Antitumor activity of tetrandrine citrate in human glioma U87 cells in vitro and in vivo.

Authors:  Jingyu Sun; Yang Zhang; Yongzhan Zhen; Ju Cui; Gang Hu; Yajun Lin
Journal:  Oncol Rep       Date:  2019-10-15       Impact factor: 3.906

8.  Alkaloids isolated from natural herbs as the anticancer agents.

Authors:  Jin-Jian Lu; Jiao-Lin Bao; Xiu-Ping Chen; Min Huang; Yi-Tao Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-04       Impact factor: 2.629

9.  Tetrandrine, a Compound Common in Chinese Traditional Medicine, Preferentially Kills Breast Cancer Tumor Initiating Cells (TICs) In Vitro.

Authors:  Wei Xu; Bisrat G Debeb; Lara Lacerda; Jessica Li; Wendy A Woodward
Journal:  Cancers (Basel)       Date:  2011-05-04       Impact factor: 6.639

10.  Synergistic effects of tetrandrine combined with ionizing radiation on a murine colorectal carcinoma‑bearing mouse model.

Authors:  Wei-Chan Lin; Wei-Hsun Wang; Yi-Hsien Lin; Jyh-Der Leu; Shan-Yun Cheng; Yu-Jen Chen; Jeng-Jong Hwang
Journal:  Oncol Rep       Date:  2018-07-12       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.